| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/08/2013 | CN103083279A Polysaccharide sulfate soft capsule |
| 05/08/2013 | CN103083268A Polysaccharide sulfate dispersible tablet |
| 05/08/2013 | CN103083267A Polysaccharide sulfate chewable tablet |
| 05/08/2013 | CN103083261A Polysaccharide sulfate freeze-dried powder injection |
| 05/08/2013 | CN103083248A Polysaccharide sulfate dry suspension |
| 05/08/2013 | CN103083244A Lysozyme curcumin nanoparticle |
| 05/08/2013 | CN102586063B Middle-aged health care wine |
| 05/08/2013 | CN102492596B Body-building and health-care medicinal liquor |
| 05/08/2013 | CN102274184B Alprostadil liposome composite medicine and industrial preparation, quality control and use |
| 05/08/2013 | CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
| 05/08/2013 | CN102229558B New silodosin crystal form delta, preparation method thereof and pharmaceutical composition containing the same |
| 05/08/2013 | CN102198166B New use of chemical ingredients of eucommia bark as nephroprotective agents |
| 05/08/2013 | CN102174362B Siberian solomonseal rhizome health-care wine and preparation method thereof |
| 05/08/2013 | CN101983055B Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 05/08/2013 | CN101821243B Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | CA2596618C Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/02/2013 | WO2013063127A1 Cyclohexylamines |
| 05/02/2013 | WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 05/02/2013 | WO2013061969A1 Oxybutynin-containing transdermal absorption preparation |
| 05/02/2013 | WO2013061588A1 Transdermally absorbed preparation |
| 05/02/2013 | WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof |
| 05/02/2013 | WO2013025984A3 Cannabinoid receptor treatments |
| 05/02/2013 | US20130109668 Azetidine compounds, compositions and methods of use |
| 05/02/2013 | US20130109665 Novel pyrazine derivatives |
| 05/02/2013 | US20130109639 Neprilysin inhibitors |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | US20130108694 Dry blend formulation of tetrahydrobiopterin |
| 05/02/2013 | US20130108650 Actriib binding agents and uses thereof |
| 05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
| 05/02/2013 | CA2853279A1 Cyclohexylamines |
| 05/01/2013 | EP2586442A1 Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 05/01/2013 | EP2585446A1 Compounds having trpv1 antagonistic activity and uses thereof |
| 05/01/2013 | EP2585103A1 Method of treatment |
| 05/01/2013 | CN1564682B Compositions for potentiating glutatthione |
| 05/01/2013 | CN103079565A Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/01/2013 | CN103071144A Marine functional food capable of inhibiting prostatic cancer and preparation method of marine functional food |
| 05/01/2013 | CN103071082A Traditional Chinese medicine composition for treating chronic nephritis |
| 05/01/2013 | CN103071071A Chinese medicinal herb formula for treating urinary calculus |
| 05/01/2013 | CN103071064A Oral traditional Chinese medicine used for treating cystitis |
| 05/01/2013 | CN103071015A Compound Cistanche deserticola tablet |
| 05/01/2013 | CN103071006A Preparation method and quality inspection method of traditional Chinese medicine for treating kidney failure |
| 05/01/2013 | CN103070995A Traditional Chinese medicine for curing prostatitis |
| 05/01/2013 | CN103070899A Method for separating and purifying total flavone of dandelion |
| 05/01/2013 | CN103070882A Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease |
| 05/01/2013 | CN102698253B Adenosine disodium triphosphate composition |
| 05/01/2013 | CN102488670B Preparation method of dual slow-release potassium citrate sustained release preparation |
| 05/01/2013 | CN102363015B Compound detoxifying pill |
| 05/01/2013 | CN102335389B Kidney-tonifying spleen-nourishing traditional Chinese medicine formula for treating chronic hepatitis B and chronic hepatitis B virus carriers |
| 05/01/2013 | CN102327591B Phlegm-eliminating pill |
| 05/01/2013 | CN102258629B Traditional Chinese medicine composition for treating prostatitis |
| 05/01/2013 | CN101890011B Pharmaceutical composition containing amlodipine and stilbestrol |
| 05/01/2013 | CN101889027B Alginic acid with low molecular weight, its salts, uses, preparative methods, pharmaceutical compositions and foods |
| 05/01/2013 | CN101495469B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives as antagonist of TRPV1 or VR1 receptor, preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN101332237B Traditional Chinese medicine composition for treating the prostatitis and preparation method thereof |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431585 Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy |
| 04/30/2013 | US8431583 Use of purine derivatives for the manufacture of a medicament |
| 04/30/2013 | CA2601129C Crystallisation and purification of glycopyrronium bromide |
| 04/30/2013 | CA2514921C Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2013 | WO2013059491A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | WO2013058833A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | WO2013058361A1 Crystals of androgen receptor antagonist compound |
| 04/25/2013 | WO2013057944A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 04/25/2013 | WO2013056547A1 Synthesis of a group of hydantoin derivatives and use thereof |
| 04/25/2013 | WO2012122340A8 Soluble guanylate cyclase activators |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102073 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 04/25/2013 | US20130101667 Cyclohexylamines |
| 04/25/2013 | US20130101627 Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101565 Use of carbonic anhydrase ii for producing a drug |
| 04/25/2013 | US20130101557 Recombinant Adenovirus Having Anti-Angiogenesis Activity |
| 04/24/2013 | EP2583981A2 Antibodies and related molecules that bind to PSCA proteins |
| 04/24/2013 | EP2583972A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient |
| 04/24/2013 | EP2583967A1 Crystal of amide compound |
| 04/24/2013 | EP2583691A1 Agent for treating renal fibrosis |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN1520303B Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 04/24/2013 | CN103068816A Crystal of amide compound |
| 04/24/2013 | CN103068401A Method of treatment |
| 04/24/2013 | CN103060158A Three-penis liquor capable of tonifying kidney |
| 04/24/2013 | CN103059165A Polysaccharide acylate and preparation method thereof |
| 04/24/2013 | CN103059088A Dammarane saponin derivatives with novel structure as well as preparation method and anti-microbial application thereof |
| 04/24/2013 | CN103058949A Thiazole derivative acting as DHODH inhibitor and its application |
| 04/24/2013 | CN103055294A Medicinal tablet for liver and gall excess fire clearing |
| 04/24/2013 | CN103055279A Chinese herbal medicine for treating spleen and lung deficiency cold retained fluid retention stomachache |
| 04/24/2013 | CN103055228A Traditional Chinese medicine formula for treating nocturnal enuresis |
| 04/24/2013 | CN103055191A Preparation method and quality detection method of traditional Chinese medicine for treating hematuresis caused by nephritis |
| 04/24/2013 | CN103055185A Application of black rice anthocyanin extract |
| 04/24/2013 | CN103055175A Traditional Chinese medicine composition for treating stranguria |
| 04/24/2013 | CN103055139A Chinese medicinal herb composition for treating gouty nephropathy |
| 04/24/2013 | CN103055110A Composition for treating cystitis and preparation method thereof |
| 04/24/2013 | CN103055033A Preparation method of traditional Chinese medicine treating obstructive nephropathy |
| 04/24/2013 | CN103054967A Medicine for treating kidney stones and preparation method thereof |
| 04/24/2013 | CN103054961A Application of Shenkang injection in preparation of medicament for treating chronic renal failure complication or complication caused by dialysis |
| 04/24/2013 | CN103054890A Application of cornuside in preparing pharmaceuticals used to cure diabetic nephropathy |
| 04/24/2013 | CN103054876A Composition, product thereof and pharmaceutical application |